|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mita MM, Mita A and Rowinsky EK: Mammalian
target of rapamycin: A new molecular target for breast cancer. Clin
Breast Cancer. 4:126–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Samuels Y, Wang Z, Bardelli A, Silliman N,
Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, et al:
High frequency of mutations of the PIK3CA gene in human cancers.
Science. 304:5542004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hennessy BT, Smith DL, Ram PT, Lu Y and
Mills GB: Exploiting the PI3K/AKT pathway for cancer drug
discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagaraja AK, Creighton CJ, Yu Z, Zhu H,
Gunaratne PH, Reid JG, Olokpa E, Itamochi H, Ueno NT, Hawkins SM,
et al: A link between mir-100 and FRAP1/mTOR in clear cell ovarian
cancer. Mol Endocrinol. 24:447–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Uesugi A, Kozaki K, Tsuruta T, Furuta M,
Morita K, Imoto I, Omura K and Inazawa J: The tumor suppressive
microRNA miR-218 targets the mTOR component Rictor and inhibits AKT
phosphorylation in oral cancer. Cancer Res. 71:5765–5778. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iwaya T, Yokobori T, Nishida N, Kogo R,
Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et
al: Downregulation of miR-144 is associated with colorectal cancer
progression via activation of mTOR signaling pathway.
Carcinogenesis. 33:2391–2397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and −5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xue M, Yao S, Hu M, Li W, Hao T, Zhou F,
Zhu X, Lu H, Qin D, Yan Q, et al: HIV-1 Nef and KSHV oncogene K1
synergistically promote angiogenesis by inducing cellular miR-718
to regulate the PTEN/AKT/mTOR signaling pathway. Nucleic Acids Res.
42:9862–9879. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang B, Wang H and Yang Z: MiR-122
inhibits cell proliferation and tumorigenesis of breast cancer by
targeting IGF1R. PLoS One. 7:e470532012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uhlmann S, Mannsperger H, Zhang JD, Horvat
EÁ, Schmidt C, Küblbeck M, Henjes F, Ward A, Tschulena U, Zweig K,
et al: Global microRNA level regulation of EGFR-driven cell-cycle
protein network in breast cancer. Mol Syst Biol. 8:5702012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lo HW, Hsu SC and Hung MC: EGFR signaling
pathway in breast cancers: From traditional signal transduction to
direct nuclear translocalization. Breast Cancer Res Treat.
95:211–218. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee CG, McCarthy S, Gruidl M, Timme C and
Yeatman TJ: MicroRNA-147 induces a mesenchymal-to-epithelial
transition (MET) and reverses EGFR inhibitor resistance. PLoS One.
9:e845972014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yao Y, Suo AL, Li ZF, et al: MicroRNA
profiling of human gastric cancer. Mol Med Rep. 2:963–970.
2009.PubMed/NCBI
|
|
17
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as Potential Oncogenic microRNA of
Squamous Cell Carcinoma of Tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han ZB, Zhong L, Teng MJ, et al:
Identification of recurrence-related microRNAs in hepatocellular
carcinoma following liver transplantation. Mol Oncol. 6:445–457.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sehgal SN, Baker H and Vézina C: Rapamycin
(AY-22,989), a new antifungal antibiotic. II. Fermentation,
isolation and characterization. J Antibiot (Tokyo). 28:727–732.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morgensztern D and McLeod HL:
PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer
Drugs. 16:797–803. 2005. View Article : Google Scholar : PubMed/NCBI
|
